References

10.1016/s0140-6736(23)02554-0

10.1016/s0140-6736(23)02554-0 · External reference

Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients with Metastatic Pheochromocytomas/Paragangliomas

10.1210/clinem/dgac657 · 2023 · External reference

Single agent axitinib in the management of patients with progressive pheochromocytoma and paraganglioma

2024 · External reference

Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma

10.1016/j.beem.2025.101977 · 2025 · External reference

Unresolved reference

External reference

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses

10.1210/clinem/dgad166 · 2023 · External reference

Antiangiogenic therapies for pheochromocytoma and paraganglioma

10.1530/erc-20-0043 · 2020 · External reference

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma

10.1097/mpa.0000000000001792 · 2021 · External reference

10.1530/erc-22-0226

10.1530/erc-22-0226 · External reference

10.7326/0003-4819-109-4-267

10.7326/0003-4819-109-4-267 · External reference

10.1002/cncr.23812

10.1002/cncr.23812 · External reference

10.1530/erc-26-0036

10.1530/erc-26-0036 · External reference

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

10.1056/nejmoa2504964 · 2025 · External reference

10.1056/nejmoa020152

10.1056/nejmoa020152 · External reference

10.1016/j.beem.2020.101416

10.1016/j.beem.2020.101416 · External reference

Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas

10.1159/000457479 · 2016 · External reference

10.1093/jnci/djt201

10.1093/jnci/djt201 · External reference

Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a singlearm, phase 2 trial

10.1016/s1470-2045(24)00133-5 · 2024 · External reference

Metastatic Disease in Phaeochromocytomas and Paragangliomas in Various Genotypes-A Systematic Review and Meta-analysis

10.1210/clinem/dgaf584 · 2026 · External reference

10.1210/clinem/dgac471

10.1210/clinem/dgac471 · External reference

10.1158/1078-0432.ccr-08-0652

10.1158/1078-0432.ccr-08-0652 · External reference

10.1016/s0140-6736(11)61613-9

10.1016/s0140-6736(11)61613-9 · External reference

10.1530/erc-16-0008

10.1530/erc-16-0008 · External reference

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma

10.3389/fendo.2023.1274239 · 2023 · External reference

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma

10.1111/cas.12546 · 2014 · External reference

10.1038/bjc.2013.145

10.1038/bjc.2013.145 · External reference